Angiotensin-induced prostacyclin release may contribute to the hypotensive action of converting enzyme inhibitors.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins / Q000494:pharmacology*; D000818:Animals; D002216:Captopril / Q000494:pharmacology; D002417:Cattle; D011464:Epoprostenol / Q000096:biosynthesis*; D007213:Indomethacin / Q000494:pharmacology; D008638:Mesenteric Arteries / Q000187:drug effects / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis*; D011817:Rabbits; D051381:Rats
D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D011453:Prostaglandins; D010643:Phenoxybenzamine; D002216:Captopril; D011433:Propranolol; D011464:Epoprostenol; D007213:Indomethacin